Offer - Urjas Oil for just ₹ 1 X
Imanib 400 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of Chronic Myelogenous Leukemia. Secondary and off-label uses of Imanib 400 Tablet have also been mentioned below.
The correct dosage of Imanib 400 Tablet depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Imanib 400 Tablet can also lead to other problems, which have been listed below. These side effects of Imanib 400 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Imanib 400 Tablet has a Severe effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Imanib 400 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Imanib 400 Tablet related warnings section.
The section on Imanib 400 Tablet contraindications lists all such conditions.
Drug reaction of Imanib 400 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Imanib 400 Tablet is not safe while driving, and is is not addictive in nature.
Imanib 400 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
2 - 12 years (Child) |
|
13 - 18 years (Adolescent) |
|
Is the use of Imanib 400 Tablet safe for pregnant women?
Imanib shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Imanib 400 Tablet safe during breastfeeding?
Imanib can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Imanib 400 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Imanib. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Imanib 400 Tablet on the Liver?
Side effects of Imanib rarely affect the liver.
What is the effect of Imanib 400 Tablet on the Heart?
The heart can be affected by Imanib. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Imanib 400 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Imanib 400 Tablet unless your doctor advises you to do so -
Is this Imanib 400 Tablet habit forming or addictive?
Forming a habit of Imanib 400 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Imanib 400 Tablet can make you feel drowsy.
Is it safe?
Imanib 400 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Imanib 400 Tablet in mental disorders is not effective.
Interaction between Food and Imanib 400 Tablet
Taking Imanib 400 Tablet with food is safe.
Interaction between Alcohol and Imanib 400 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Imanib 400 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gleevec (imatinib mesylate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 674-676
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 869